Final Height and Endocrine Complications in Patients with β-Thalassemia Intermedia: Our Experience in Non-Transfused Versus Infrequently Transfused Patients and Correlations with Liver Iron Content

BACKGROUND: β-thalassemia intermedia (TI) spans a wide spectrum of severity and carries higher morbidity than previously recognized, including extramedullary hematopoiesis, leg ulcers, gallstones, thrombosis, secondary heart failure, pulmonary hypertension, skeletal deformity, growth retardation and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yassin, Mohamed A., Soliman, Ashraf T., De Sanctis, Vincenzo, Yassin, Khadra S., Abdulla, Mohammad AJ.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548215/
https://www.ncbi.nlm.nih.gov/pubmed/31205630
http://dx.doi.org/10.4084/MJHID.2019.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548215/
https://www.ncbi.nlm.nih.gov/pubmed/31205630
http://dx.doi.org/10.4084/MJHID.2019.026

Ejemplares similares